http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102641246-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21207c582701b3492b563f7bece0c122
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
filingDate 2012-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5f5eed05f2fd1eaaef31c2bad162fdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2fecf8e049d0077be0d77be4f43ec7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ceff2e851fbd4f60bc485e7435abaca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3af63ba0d97197e352bad6cb7590514a
publicationDate 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102641246-B
titleOfInvention Anti-tumor double-drug nano drug carrying microsphere and preparation method thereof
abstract The invention relates to an anti-tumor drug, in particular to an anti-tumor double-drug nano drug carrying microsphere and a preparation method thereof. The double-drug nano drug carrying microsphere disclosed by the invention is formed by mixing paclitaxel (Ptx), concordant remedies and drug carrying materials, wherein the concordant remedies are tetrandrine (Tet), or curcumin (Cum) or resveratrol (Res), the drug carrying material is amphiphilic block copolymer, namely polycaprolactone-polyethylene glycol (mPEG-PCL) or polylactic acid-polyethylene glycol (mPEG-PLA) or polyglycolic acid-polyethylene glycol (mPEG-PLGA), synthesized by polycaprolactone or polylactic acid or polyglycolic acid and polyethylene glycol. The preparation method disclosed by the invention comprises the steps of dosage, medicine dissolving, dilution, purification, filtering, drying or freeze drying and the like to obtain the anti-tumor double-drug nano drug carrying microsphere or finished freeze-drying product. According to the anti-tumor double-drug nano drug carrying microsphere and the preparation method thereof, the concordant remedies have the synergistic effect of reinforcing the tumor inhibiting capability of the paclitaxel so as to improve the pesticide effect of the double drugs for resisting tumor in a synergy manner.
priorityDate 2012-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24140
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP42881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07286
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP42867
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP42864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5EA65
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO64314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451822344
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP39465
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9H3H5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6971205
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9T1W1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22227373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CD61
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23338
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP52894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557772
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP52893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415750692
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP52892
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ10334
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP96000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54MJ7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430895435
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP34106

Total number of triples: 58.